MARYAM RAHMANIAN: Open Payments
NPI 1851913768 · WEST HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 39 payments from 13 companies in 2025. Trend: 2023 $1,193 · 2024 $1,667 · 2025 $1,139
Food & beverage: $1,139
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $273 |
| AstraZeneca Pharmaceuticals LP | 6 | $207 |
| Janssen Pharmaceuticals, Inc | 1 | $144 |
| Amgen Inc. | 5 | $125 |
| PFIZER INC. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
Products named: VERQUVO, LOKELMA, SPRAVATO, REPATHA, Kerendia, FARXIGA, JARDIANCE, VYNDAQEL.
Industry payments across CA — which companies pay providers there.
